Radiation Exposure Reduction in Supraventricular Tachycardia Ablation (NO-PARTY)
Near Zero Fluoroscopic Exposure During Catheter Ablation of Supraventricular Arrhythmias
Sponsor: Abbott Medical Devices
Listed as NCT01132274, this PHASE4 trial focuses on Supraventricular Tachycardias and remains completed. Sponsored by Abbott Medical Devices, it has been updated 6 times since 2009, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Feb 2019 — Jan 2021 [monthly]
Completed PHASE4
-
Jun 2018 — Feb 2019 [monthly]
Completed PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Dec 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
- CNR Institute of Clinical Physiology, Pisa, Italy
- Catholic University of the Sacred Heart
For direct contact, visit the study record on ClinicalTrials.gov .